Related references
Note: Only part of the references are listed.Reinvigorating the public health response to dementia
The Lancet Public Health
Lancet Public Health (2021)
Identifying dementia cases with routinely collected health data: A systematic review
Tim Wilkinson et al.
ALZHEIMERS & DEMENTIA (2018)
Association of Mild Traumatic Brain Injury With and Without Loss of Consciousness With Dementia in US Military Veterans
Deborah E. Barnes et al.
JAMA NEUROLOGY (2018)
Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study
Chieh-Hsiang Lu et al.
DIABETOLOGIA (2018)
Effects of pioglitazone on the incidence of dementia in patients with diabetes
Ping-Song Chou et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes
Ariela R. Orkaby et al.
NEUROLOGY (2017)
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
W. N. Kernan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effect of pioglitazone medication on the incidence of dementia
Michael T. Heneka et al.
ANNALS OF NEUROLOGY (2015)
Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review
Stefan L. C. Geijselaers et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Type 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis
Chin Cheng et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors
Aramesh Saremi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies
G. Cheng et al.
INTERNAL MEDICINE JOURNAL (2012)
Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
Chih-Cheng Hsu et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dara L. Dickstein et al.
MOUNT SINAI JOURNAL OF MEDICINE (2010)
How does diabetes accelerate Alzheimer disease pathology?
Catrina Sims-Robinson et al.
NATURE REVIEWS NEUROLOGY (2010)
Regulatory Action on Rosiglitazone by the US Food and Drug Administration
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Central obesity and increased risk of dementia more than three decades later
R. A. Whitmer et al.
NEUROLOGY (2008)
Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits
Adit A Ginde et al.
BMC Endocrine Disorders (2008)
How doctors choose medications to treat type 2 diabetes - A national survey of specialists and academic generalists
Richard W. Grant et al.
DIABETES CARE (2007)
Diabetes mellitus and risk of developing Alzheimer disease - Results from the Framingham study
Abimbola Akomolafe et al.
ARCHIVES OF NEUROLOGY (2006)
Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype
MA Reger et al.
NEUROBIOLOGY OF AGING (2006)
Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review
BR Shah et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
Thiazolidinedione use, fluid retention, and congestive heart failure - A consensus statement from the American Heart Association and American Diabetes Association
RW Nesto et al.
CIRCULATION (2003)
Vascular dementia in a population-based autopsy study
DS Knopman et al.
ARCHIVES OF NEUROLOGY (2003)
The accuracy of medicare claims data in identifying Alzheimer's disease
DH Taylor et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2002)
Patient compliance and persistence with antihyperglycemic drug regimens: Evaluation of a Medicaid patient population with type 2 diabetes mellitus
G Dailey et al.
CLINICAL THERAPEUTICS (2001)
Efficacy of troglitazone on body fat distribution in type 2 diabetes
S Akazawa et al.
DIABETES CARE (2000)
Share Paper
